Clinical Trials
125 trialsNADOM
St Vincent's Hospital, Sydney
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
H. Lee Moffitt Cancer Center and Research Institute
iSITE
The Wellcome Sanger Institute
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Immunocore Ltd
PALANGI3
Centre Oscar Lambret
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Emory University
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
O-Mel-Sora
University Hospital, Caen
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
University of Miami
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma
University Hospital Erlangen
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Massachusetts Eye and Ear Infirmary
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
Institut Curie
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Thomas Jefferson University
HAITILS
Vastra Gotaland Region
ctDNA R0
Institut Curie
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)
Institut Curie
EARLY TOGETHER
Institut Curie
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
HonorHealth Research Institute
imMUno
Institut Curie
Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Institut Curie
Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
Thomas Jefferson University
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
Memorial Sloan Kettering Cancer Center
A Study of SEA-CD40 Given With Other Drugs in Cancers
Seagen Inc.
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver
Thomas Jefferson University
DeCOG
University Hospital, Essen
SCANDIUM II
Vastra Gotaland Region
PROTECT
Centre Hospitalier Universitaire de Nice
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Aura Biosciences
Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy
Centre Hospitalier Universitaire de Nice
SirTac
Charite University, Berlin, Germany
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
University of Michigan Rogel Cancer Center
Mel66
University of Virginia
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
Neoadjuvant and Adjuvant Checkpoint Blockade
M.D. Anderson Cancer Center
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Vaccine Therapy in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
Study in Subjects With Small Primary Choroidal Melanoma
Aura Biosciences
ctDNA MU
Institut Curie
FOCUS
Delcath Systems Inc.
PEMDAC
Vastra Gotaland Region
Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Columbia University
TIMAR1
Perspective Therapeutics
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
University of Florida
Intermittent Selumetinib for Uveal Melanoma
Columbia University
Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Columbia University
Vascular Response to Brachytherapy Using Functional OCT
OHSU Knight Cancer Institute
CLEVER
Viralytics
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Immunocore Ltd
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
Hoffmann-La Roche